GHK-Cu

GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper-binding tripeptide with documented roles in wound healing, tissue remodeling, and skin regeneration.

Profile · 01

Overview

GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper-binding tripeptide with documented roles in wound healing, tissue remodeling, and skin regeneration. Research demonstrates activity in gene regulation related to collagen synthesis, antioxidant defense, and anti-inflammatory pathways. It is not FDA-approved for any indication.

Preclinical and clinical studies support its role in skin rejuvenation and tissue repair, with genomic studies showing modulation of regenerative gene expression. This protocol presents a subcutaneous approach with gradual titration over 8–12+ weeks.

At a Glance

Goal
Support wound healing, skin rejuvenation, tissue remodeling, and anti-inflammatory processes
Categories
Tissue RepairSkin HealthAnti-AgingAnti-Inflammatory
Synergistic
BPC-157 · TB-500 (Thymosin Beta-4) · Collagen Peptides · Vitamin C
Profile · 02

Protocol

Suggested titration approach starting at 1.0 mg and increasing every four weeks, administered 5 days per week.

Typical daily range
1.0–2.0 mg once daily, 5 days/week (gradual titration)
Start
1.0 mg daily; increase by 0.5 mg every 4 weeks as tolerated
Target
2.0 mg daily by Weeks 9–12+
Frequency
Once per day, 5 days per week (subcutaneous)
Cycle Length
8–12 weeks; take 2–4 weeks off before repeating
Timing
Any consistent time; rotate injection sites
Route
Subcutaneous
Cycle
8–12 weeks on, 2–4 weeks off

Inject once daily subcutaneously, 5 days per week (weekdays on, weekends off). For administrations of 10 units or fewer, consider using 30- or 50-unit insulin syringes for improved readability. Dosing is based on clinical practice and empirical use; no official human dosing guidelines exist. Preclinical studies show activity at approximately 0.5 mcg/kg in rodent models, while clinical practice employs milligram-range dosing in humans. Alternative protocol: 2.0 mg three times per week (e.g., Monday/Wednesday/Friday) instead of the daily 5×/week schedule.

Dose progression

Weeks 1–4
1.0 mg (1,000 mcg)
Weeks 5–8
1.5 mg (1,500 mcg)
Weeks 9–12+
2.0 mg (2,000 mcg)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How GHK-Cu works.

GHK-Cu is a naturally occurring tripeptide that complexes with copper(II) ions to modulate a wide range of biological processes. Copper serves as a cofactor for enzymes critical to collagen synthesis (lysyl oxidase) and antioxidant defense (superoxide dismutase). Research indicates involvement in wound healing through enhanced collagen and decorin gene expression, activation of tissue remodeling pathways, and regulation of genes associated with antioxidant defense and anti-inflammatory responses. Genomic studies show GHK-Cu modulates expression patterns in a significant proportion of human genes toward a regenerative, anti-aging phenotype. The peptide demonstrates multifunctional activity across skin, nervous system, and vascular tissue in preclinical models. Clinical studies have documented increased skin thickness, improved dermal collagen density, and reduced wrinkle depth with topical application.

Science · 02

Effects

Observations from clinical or preclinical literature.

Supports wound healing and tissue repair through collagen synthesis and remodeling pathways (preclinical and clinical data)
Demonstrates positive regulatory effects on genes related to antioxidant enzymes, growth factors, and anti-inflammatory signaling
Shows activity in nervous system function and cognitive pathways in preclinical models
Clinical studies document increased skin thickness, improved dermal collagen density, and reduced wrinkle depth
Observed enlargement of hair follicles and increased growth rate in preclinical models
Generally well tolerated; most common side effects are mild injection-site reactions (temporary redness, itching) with subcutaneous administration
No official human dosing guidelines exist; protocols are based on clinical practice and empirical use
Science · 03

Caution

Individuals with Wilson's disease or other copper metabolism disorders should avoid use due to the copper component
Not recommended during pregnancy or breastfeeding (no safety data available)
Use with caution if taking medications that affect copper levels or copper metabolism
Consult a healthcare provider before use if you have any chronic medical conditions or liver disease

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Zinc
Supports wound healing and balances copper–zinc ratio; important when supplementing copper-containing peptides.
Vitamin C
Essential cofactor for collagen synthesis and enhances tissue repair synergistically with GHK-Cu.
Copper
While GHK-Cu contains copper, ensuring adequate dietary copper supports overall enzyme function.
Hyaluronic acid
Supports skin hydration and extracellular matrix health complementary to GHK-Cu's collagen-promoting activity.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain adequate protein intake to support collagen synthesis and tissue repair
Ensure sufficient hydration and micronutrient status (particularly copper, zinc, vitamin C)
Prioritize sleep quality and stress management to support regenerative processes
Consider combining with appropriate skincare or wound-care protocols as relevant to individual goals
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Skin quality and elasticity — monitor changes in skin thickness, texture, and wrinkle depth over the protocol
  2. Wound healing rate — if using for injury recovery, track closure time and tissue quality
  3. Hair quality and growth — observe changes in hair thickness and growth rate if relevant to goals
  4. Injection-site reactions — note any redness, swelling, or discomfort to guide site rotation
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

Serum copper
Monitor copper levels to ensure they remain within normal range during GHK-Cu use.
Ceruloplasmin
Copper-binding protein; helps assess copper metabolism status.
Zinc levels
Monitor copper-to-zinc ratio, as supplemental copper can affect zinc balance.
CBC (Complete Blood Count)
Monitor overall health markers.
CMP (Comprehensive Metabolic Panel)
Assess liver and kidney function during peptide use.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 100 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean vial stopper and injection site with alcohol swabs; allow both to air-dry completely
Pinch a fold of skin; insert needle at 45–90° into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Withdraw needle at the same angle as insertion; apply gentle pressure with cotton swab if needed (do not rub)
Rotate sites systematically (abdomen at least 1 inch from navel, outer thighs, upper arms) to avoid lipohypertrophy
Discard used syringes immediately in sharps container per WHO guidelines

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use new sterile insulin syringes for each injection; dispose in sharps container
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation
Inject slowly; withdraw needle at the same angle as insertion; apply gentle pressure with cotton swab if needed (do not rub)
Document dose, date, and injection site to maintain consistency and track rotation
GHK-Cu is not FDA-approved; no official human dosing guidelines exist; clinical decisions should involve qualified healthcare providers
Reference · 02

References

  1. Journal of Biological Chemistry
    Pickart L et al., "GHK-Cu: tripeptide-copper complex with wound healing and tissue remodeling activity".
    https://www.jbc.org/
  2. BioMed Research International (PMC)
    Pickart L et al., "GHK peptide as a natural modulator of multiple cellular pathways in skin biology".
    https://pmc.ncbi.nlm.nih.gov/
  3. Gene (Elsevier)
    Pickart L and Margolina A, "Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data".
    https://pubmed.ncbi.nlm.nih.gov/22763378/
  4. Oxidative Medicine and Cellular Longevity (PMC)
    "GHK-Cu modulation of antioxidant defense genes and anti-inflammatory signaling".
    https://pmc.ncbi.nlm.nih.gov/
  5. Dermatologic Surgery
    "Clinical studies on GHK-Cu effects on skin thickness, collagen density, and wrinkle depth".
    https://journals.lww.com/dermatologicsurgery/
  6. JPT Peptide Technologies
    "Peptide stability and storage guidelines".
    https://www.jpt.com/
  7. MedlinePlus
    "Subcutaneous injection technique and site rotation guidance".
    https://medlineplus.gov/ency/patientinstructions/000430.htm
  8. CDC
    "Vaccine administration: subcutaneous route (angle/site; no aspiration)".
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
  9. WHO (NCBI Bookshelf)
    "Guideline on safety-engineered syringes for IM, ID, and SC injections in health care settings (2016)".
    https://www.ncbi.nlm.nih.gov/books/NBK390474/
  10. PMC
    "Pharmacologic considerations of the subcutaneous route".
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6822791/
  11. Pure Lab Peptides
    "GHK-Cu 50 mg product documentation and Certificate of Analysis".
    https://purelabpeptides.com/
On this page